Validity of Web-Based OSDI-6 Questionnaire in a Chinese Adult Population
1 other identifier
observational
270
1 country
1
Brief Summary
This study aimed to evaluate the validity of the Chinese translation version of OSDI-6 (C-OSDI-6) in a theoretical set-up of two questionnaire groups for dry eye
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 28, 2023
CompletedStudy Start
First participant enrolled
December 1, 2023
CompletedFirst Posted
Study publicly available on registry
December 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 17, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 17, 2024
CompletedFebruary 20, 2024
November 1, 2023
3 months
November 28, 2023
February 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
OSDI12
The patient will answer each question on a scale ranging from 0 to 4, with 0 indicating 'none of the time' and 4 indicating 'all of the time'. If a certain question is deemed irrelevant, it will be marked as 'not applicable (N/A)' and excluded from the analysis. The OSDI total score is calculated according to the following formula. The scale ranges from 0 to 100, with higher scores representing more severe cases of dry eye syndrome
Baseline
Study Arms (1)
Study group
Dry eye patients were recruited to fill in the questionnaire
Eligibility Criteria
Patients who have been diagnosed with dry eye
You may qualify if:
- Diagnosed dry eye
- Able and willing to comply with the schedule
- Able to read and understand the C-OSDI-12 questionnaire independently
You may not qualify if:
- The researchers judged to be not suitable
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- He Eye Hospitallead
Study Sites (1)
He Eye Hospital
Shenyang, None Selected, 110034, China
Related Publications (6)
Jones L, Downie LE, Korb D, Benitez-Del-Castillo JM, Dana R, Deng SX, Dong PN, Geerling G, Hida RY, Liu Y, Seo KY, Tauber J, Wakamatsu TH, Xu J, Wolffsohn JS, Craig JP. TFOS DEWS II Management and Therapy Report. Ocul Surf. 2017 Jul;15(3):575-628. doi: 10.1016/j.jtos.2017.05.006. Epub 2017 Jul 20.
PMID: 28736343BACKGROUNDCraig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, Liu Z, Nelson JD, Nichols JJ, Tsubota K, Stapleton F. TFOS DEWS II Definition and Classification Report. Ocul Surf. 2017 Jul;15(3):276-283. doi: 10.1016/j.jtos.2017.05.008. Epub 2017 Jul 20.
PMID: 28736335BACKGROUNDSchiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000 May;118(5):615-21. doi: 10.1001/archopht.118.5.615.
PMID: 10815152BACKGROUNDNichols KK, Mitchell GL, Zadnik K. Performance and repeatability of the NEI-VFQ-25 in patients with dry eye. Cornea. 2002 Aug;21(6):578-83. doi: 10.1097/00003226-200208000-00009.
PMID: 12131034BACKGROUNDLu F, Tao A, Hu Y, Tao W, Lu P. Evaluation of Reliability and Validity of Three Common Dry Eye Questionnaires in Chinese. J Ophthalmol. 2018 Aug 27;2018:2401213. doi: 10.1155/2018/2401213. eCollection 2018.
PMID: 30225139BACKGROUNDMidorikawa-Inomata A, Inomata T, Nojiri S, Nakamura M, Iwagami M, Fujimoto K, Okumura Y, Iwata N, Eguchi A, Hasegawa H, Kinouchi H, Murakami A, Kobayashi H. Reliability and validity of the Japanese version of the Ocular Surface Disease Index for dry eye disease. BMJ Open. 2019 Nov 25;9(11):e033940. doi: 10.1136/bmjopen-2019-033940.
PMID: 31772113BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 28, 2023
First Posted
December 6, 2023
Study Start
December 1, 2023
Primary Completion
February 17, 2024
Study Completion
February 17, 2024
Last Updated
February 20, 2024
Record last verified: 2023-11